Giant Biogene Holding Co., Ltd.
2367
Clasificación en acciones
#5026
Giant Biogene Holding Co., Ltd. operates as an investment holding entity,... Giant Biogene Holding Co., Ltd. operates as an investment holding entity, primarily engaged in the research, development, production, and sale of beauty and wellness products based on bioactive materials throughout the People's Republic of China. The company also manufactures functional foods leveraging rare ginsenosides technology and provides medical devices. Its diverse product range, which includes specialized skincare, medical dressings, and nutritional supplements, is marketed predominantly under brand names such as Comfy, Collgene, Keyu, Kehen, Kefuping, Leeyen, SKIGIN, and Shengan. Established in 2000, Giant Biogene Holding Co., Ltd. maintains its headquarters in Xi'an, PRC.
Precio por acción
$2.67
Capitalización bursátil
$2.84B
Cambio (1 día)
-6.09%
Cambio (1 año)
-46.20%
País
CN
Comercio Giant Biogene Holding Co., Ltd. (2367)
Categoría
Consumer Defensive
Ratio P/B de Giant Biogene Holding Co., Ltd. (2367)
Ratio P/B al October 2026 TTM: 2.00
Según los informes financieros más recientes y el precio de las acciones de Giant Biogene Holding Co., Ltd., el ratio P/B actual (TTM) es 2.00. Al final de 2024, el ratio P/B era 6.60.
Historial del ratio P/B de Giant Biogene Holding Co., Ltd. desde 2019 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 2.00 | -37.21% |
| 2025 | 3.19 | -51.68% |
| 2024 | 6.60 | -9.00% |
| 2023 | 7.25 | -29.02% |
| 2022 | 10.22 | -50.98% |
| 2021 | 20.85 | -57.14% |
| 2020 | 48.63 | 136.00% |
| 2019 | 20.61 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 6.9837 | 248.68% |
US
|
|
| 6.3772 | 218.40% |
FR
|
|
| 315.2455 | 15,639.45% |
US
|
|
| 8.7627 | 337.50% |
IN
|
|
| 9.8894 | 393.75% |
US
|
